hydroxyindoleacetic acid has been researched along with tacrine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shillcutt, S; Soininen, H; Unni, L | 1 |
| Ahlin, A; Hassan, M; Junthé, T; Nybäck, H | 1 |
| Alhainen, K; Helkala, EL; Reinikainen, K; Riekkinen, P | 1 |
1 trial(s) available for hydroxyindoleacetic acid and tacrine
| Article | Year |
|---|---|
Clinical experiences and biochemical findings with tacrine (THA).
Topics: Administration, Rectal; Alzheimer Disease; Biogenic Monoamines; Cross-Sectional Studies; Double-Blind Method; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Liver; Male; Neuropsychological Tests; Placebos; Tacrine | 1993 |
2 other study(ies) available for hydroxyindoleacetic acid and tacrine
| Article | Year |
|---|---|
Effect of acute and chronic cholinesterase inhibition on biogenic amines in rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amines; Brain; Cholinesterase Inhibitors; Cholinesterases; Dichlorvos; Dopamine; Drug Administration Schedule; Homovanillic Acid; Hydroxyindoleacetic Acid; Male; Norepinephrine; Physostigmine; Rats; Rats, Inbred Strains; Reference Values; Serotonin; Tacrine; Trichlorfon | 1990 |
The relationship of cerebrospinal fluid monoamine metabolites with clinical response to tetrahydroaminoacridine in patients with Alzheimer's disease.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Biogenic Monoamines; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Tacrine | 1993 |